Diagnostics & biomarkers

London’s diagnostics industry demonstrated its strength, playing a leading role in the UK and global response to the COVID-19 pandemic. Now, the sector is turning its focus to new challenges across healthcare.

$3bn

combined company value founded in London

Imperial College London provided the

first real world evidence

for duration of COVID-19 infectiousness

103

diagnostics and biomarkers companies based in London

>100

companies supported by the NIHR In Vitro Diagnostics HealthTech Research Centre

Top VC funders

Key research centres

Success stories:

The London Testing Alliance

Coordinated by MedCity, the London Testing Alliance brought together industry, universities and researchers to scale up testing capacity during the COVID-19 pandemic. Its success led to the establishment of the Diagnostics Growth Hub

Learn more

Success stories:

DnaNudge

DnaNudge, an Imperial College London start-up, developed a lab-free, rapid and reliable PCR test for COVID-19, which delivered results in under 90 minutes.
DnaNudge was recognised as a Wired trailblazer in 2023.

Learn more

Programmes & initiatives

MedCity Diagnostics Growth Hub offers a ‘one stop shop’ for companies to access support and guidance on a range of areas including R&D, clinical trials, manufacturing, funding and regulatory issues. Learn more
The London In Vitro Diagnostics Co-operative is one of four NIHR centres that generate evidence to support diagnostic test development. Learn more
Collaborate to Innovate London Diagnostics is a 12-month programme to help diagnostics entrepreneurs progress their R&D, test, validate, scale-up, and implement their products. Learn more
For other relevant support programmes and funding see Support.